Cheng-shyong A. Wu
Taoyuan, TNQ 33302, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Correction: Chang et al. Inhibition of CCAR1, a Coactivator of β-Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells. Int. J. Mol. Sci. 2017, 18, 460.
Journal: International journal of molecular sciences
Published: May 12, 2026
Cardiovascular outcomes in hepatitis C virus infected patients treated with direct acting antiviral therapy: a retrospective multi-institutional study.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 05, 2023
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis.
Journal: Viruses
Published: November 19, 2022
Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients.
Journal: World journal of gastroenterology
Published: April 11, 2021
2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis.
Journal: International journal of molecular sciences
Published: July 16, 2020
Helios Expression in Tumor-Infiltrating Lymphocytes Correlates with Overall Survival of Advanced Gastric Cancer Patients.
Journal: Life (Basel, Switzerland)
Published: July 14, 2020
Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer.
Journal: Frontiers in oncology
Published: June 24, 2020
Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
Journal: PloS one
Published: February 18, 2019
Last Updated: 09/26/2026